MAML3
Mastermind-like protein 3
Also known as: CAGH3, GDN, KIAA1816, MAM2, MAML3_HUMAN, TNRC3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96JK9
- Gene
- MAML3
- Ensembl
- ENSG00000196782
- Chromosome
- 4
- Canonical length
- 1138 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nuclear speckles
OverviewNCBI Gene
Enables transcription coactivator activity. Involved in Notch signaling pathway and positive regulation of transcription by RNA polymerase II. Located in nuclear speck. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1138 residues, UniProt reviewed canonical sequence.
>Q96JK9|MAML3
1 MGDFAAPAAA ANGSSICINS SLNSSLGGAG IGVNNTPNST PAAPSSNHPA AGGCGGSGGP
61 GGGSAAVPKH STVVERLRQR IEGCRRHHVN CENRYQQAQV EQLELERRDT VSLYQRTLEQ
121 RAKKSGAGTG KQQHPSKPQQ DAEAASAEQR NHTLIMLQET VKRKLEGARS PLNGDQQNGA
181 CDGNFSPTSK RIRKDISAGM EAINNLPSNM PLPSASPLHQ LDLKPSLPLQ NSGTHTPGLL
241 EDLSKNGRLP EIKLPVNGCS DLEDSFTILQ SKDLKQEPLD DPTCIDTSET SLSNQNKLFS
301 DINLNDQEWQ ELIDELANTV PEDDIQDLFN EDFEEKKEPE FSQPATETPL SQESASVKSD
361 PSHSPFAHVS MGSPQARPSS SGPPFSTVST ATSLPSVAST PAAPNPASSP ANCAVQSPQT
421 PNQAHTPGQA PPRPGNGYLL NPAAVTVAGS ASGPVAVPSS DMSPAEQLKQ MAAQQQQRAK
481 LMQQKQQQQQ QQQQQQQQQQ QQQQQQQQQQ HSNQTSNWSP LGPPSSPYGA AFTAEKPNSP
541 MMYPQAFNNQ NPIVPPMANN LQKTTMNNYL PQNHMNMINQ QPNNLGTNSL NKQHNILTYG
601 NTKPLTHFNA DLSQRMTPPV ANPNKNPLMP YIQQQQQQQQ QQQQQQQQQQ PPPPQLQAPR
661 AHLSEDQKRL LLMKQKGVMN QPMAYAALPS HGQEQHPVGL PRTTGPMQSS VPPGSGGMVS
721 GASPAGPGFL GSQPQAAIMK QMLIDQRAQL IEQQKQQFLR EQRQQQQQQQ QQILAEQQLQ
781 QSHLPRQHLQ PQRNPYPVQQ VNQFQGSPQD IAAVRSQAAL QSMRTSRLMA QNAGMMGIGP
841 SQNPGTMATA AAQSEMGLAP YSTTPTSQPG MYNMSTGMTQ MLQHPNQSGM SITHNQAQGP
901 RQPASGQGVG MVSGFGQSML VNSAITQQHP QMKGPVGQAL PRPQAPPRLQ SLMGTVQQGA
961 QSWQQRSLQG MPGRTSGELG PFNNGASYPL QAGQPRLTKQ HFPQGLSQSV VDANTGTVRT
1021 LNPAAMGRQM MPSLPGQQGT SQARPMVMSG LSQGVPGMPA FSQPPAQQQI PSGSFAPSSQ
1081 SQAYERNAPQ DVSYNYSGDG AGGSFPGLPD GADLVDSIIK GGPGDEWMQE LDELFGNPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAML3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.67
- Highest tissue expression
- 7.6 nTPM
Expression across tissuesHPA
Tissue
- ovary: 7.6 nTPM
- skin: 7.4 nTPM
- cerebellum: 6.5 nTPM
- endometrium: 6.1 nTPM
- pancreas: 6 nTPM
- salivary gland: 5.6 nTPM
Single-cell type
- neutrophils: 2,834 nCPM
- lactotrophs: 1,633 nCPM
- microglia: 1,515 nCPM
- corticotrophs: 1,329 nCPM
- gonadotrophs: 1,255 nCPM
- thyrotrophs: 1,139 nCPM
Immune cell
- basophil: 5.7 nTPM
- neutrophil: 3.1 nTPM
- eosinophil: 1.8 nTPM
- NK-cell: 1.5 nTPM
- classical monocyte: 1.4 nTPM
- myeloid DC: 1.4 nTPM
Brain region
- cerebellum: 24 nTPM
- pons: 9.7 nTPM
- medulla oblongata: 9.5 nTPM
- hypothalamus: 9 nTPM
- spinal cord: 8.3 nTPM
- white matter: 8.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.22
- gnomAD pLI
- 1
- gnomAD missense Z
- 0.9
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- Notch signaling pathway
- positive regulation of transcription by RNA polymerase II
- positive regulation of transcription of Notch receptor target
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MAML3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAML3 as an antibody target. Whether an autoantibody or antibody against MAML3 could matter depends on whether native MAML3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAML3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MAML3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...